GH Research GHRS
NASDAQ GHRS
$22.94 +0.08 (+0.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

GH Research (GHRS) Long-Term Investments (2021 - 2025)

Updated

GH Research's Long-Term Investments was $134.24 million in Q4 2025, up 5.9% from $126.77 million a year earlier.

Analysis

GH Research (GHRS) Long-Term Investments (2021 - 2025) Analysis & Trends

From Q4 2021 onward, GH Research has reported Long-Term Investments for 5 quarters.

  • Long-Term Investments has now increased for four consecutive years, with a four-year compound annual growth rate of 2.4% (FY2021 to FY2025).
  • In earlier years, Long-Term Investments was $126.77 million in FY2024 (+0.7%), $125.87 million in FY2023 (+1.8%), $123.66 million in FY2022 (+1.3%) and $122.08 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 266.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.62 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.56 Bn
10 GH Research 1.42 Bn 257.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 134.24 Mn
Dec 31, 2024 126.77 Mn
Dec 31, 2023 125.87 Mn
Dec 31, 2022 123.66 Mn
Dec 31, 2021 122.08 Mn
API Access

GH Research Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=GHRS&period=max&api_key=YOUR_API_KEY